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ding, for only six weeks. The exact relationship between therapy and the exudates cannot be determined at present but a dramatic and prolonged remission in ocular signs followed reduction in the dosage of corticotrophin.
Finally, 6 rheumatoid arthritic patients developed acutely red eyes, clinically a nonspecific conjunctivitis, after sudden withdrawal ofsystemic steroid therapy. None of them had any history of eye disease and all had been examined prior to these episodes. Biopsy of one patient's conjuctiva revealed a nonspecific chronic round cell infiltrate with no predominance of eosinophils. Release from the suppressing effect of steroid therapy seems to be the most plausible explanation. AJl the red eyes resolved in a few days without treatment.
Quantitative Assessment of Colour Vision in Tobacco Amblyopia [Summary] by I A Chisholm FRCSEd (Tennent Institute ofOphthalmology, University ofGlasgow, Western Infirmary, Glasgow WI) One ofthe diagnostic criteria of tobacco amblyopia is the finding of an acquired colour defect. The Farnsworth Munsell 100 Hue test was found to be the most useful means of analysing the colour defect in these patients, prior to and whilst on treatment. The patient's error score for the test can be calculated and expressed numerically or graphically. In a group of 65 patients whose mean age was 67 years, suffering from untreated tobacco amblyopia, the mean error score for the Farnsworth Munsell 100 Hue test was 732 ± 236. Apart from 5 of the patients, all received parenteral vitamin B12 therapy. Initially, they were given either cyanocobalamin or hydroxocobalamin and, as previously reported by Chisholm et al. (1967) , the improvement in colour vision, indicated by a falling 100 Hue error score, was greater with hydroxocobalamin than cyanocobalamin. All patients were subsequently transferred to hydro-xocobalamin therapy at a dose of 1,000 ,g daily for the first 14 days and then thrice weekly. Adjustments were made dependent on the patient's response. The patients were advised that it was not necessary to alter their smoking habits. Improvement in colour discrimination may be observed by studying the change in the 100 Hue profile or in the numerical error score. With time there is a noticeable shrinkage of the area of error in profile. Patients with tobacco amblyopia were found to improve when given hydroxocobalamin even when continuing to smoke and their rate of recovery was as good as that obtained when the tobacco habit was given up. Patients with addisonian pernicious anxmia with field defects, and who smoke, improve more slowly than patients with tobacco ambylopia in which diabetes is present. Speakers for the motion were Mr Dermot Pierse and Mr John Dobree; against the motion, Mr Eric Arnott and Mr Peter Blaxter.
